Literature DB >> 33211253

Basic Amino Acids Within the Juxtamembrane Domain of the Epidermal Growth Factor Receptor Regulate Receptor Dimerization and Auto-phosphorylation.

Jordan D Mohr1,2, Alice Wagenknecht-Wiesner1, David A Holowka1, Barbara A Baird3,4.   

Abstract

Epidermal growth factor receptor (EGFR) dysregulation is observed in many human cancers and is both a cause of oncogenesis and a target for chemotherapy. We previously showed that partial charge neutralization of the juxtamembrane (JX) region of EGFR via the EGFR R1-6 mutant construct induces constitutive receptor activation and transformation of NIH 3T3 cells, both from the plasma membrane and from the ER when combined with the ER-retaining L417H mutation (Bryant et al. in J Biol Chem 288:34930-34942, 2013). Here, we use chemical crosslinking and immunoblotting to show that these mutant constructs form constitutive, phosphorylated dimers in both the plasma membrane and the ER. Furthermore, we combine this electrostatic perturbation with conformationally-restricted receptor mutants to provide evidence that activation of EGFR R1-6 dimers requires functional coupling both between the EGFR extracellular dimerization arms and between intracellular tyrosine kinase domains. These findings provide evidence that the electrostatic charge of the JX region normally serves as a negative regulator of functional dimerization of EGFR.

Entities:  

Keywords:  Dimerization; EGFR; Electrostatic regulation; Juxtamembrane region

Mesh:

Substances:

Year:  2020        PMID: 33211253      PMCID: PMC7721285          DOI: 10.1007/s10930-020-09943-8

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  42 in total

1.  Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

Authors:  M X Sliwkowski; G Schaefer; R W Akita; J A Lofgren; V D Fitzpatrick; A Nuijens; B M Fendly; R A Cerione; R L Vandlen; K L Carraway
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

Review 2.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 3.  Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases.

Authors:  Nicholas F Endres; Tiago Barros; Aaron J Cantor; John Kuriyan
Journal:  Trends Biochem Sci       Date:  2014-09-18       Impact factor: 13.807

Review 4.  Receptor tyrosine kinase activation: From the ligand perspective.

Authors:  Raphael Trenker; Natalia Jura
Journal:  Curr Opin Cell Biol       Date:  2020-02-27       Impact factor: 8.382

5.  Mutations in the polybasic juxtamembrane sequence of both plasma membrane- and endoplasmic reticulum-localized epidermal growth factor receptors confer ligand-independent cell transformation.

Authors:  Kirsten L Bryant; Marc A Antonyak; Richard A Cerione; Barbara Baird; David Holowka
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

Review 6.  The EGFR family: not so prototypical receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger; Kathryn M Ferguson
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-04-01       Impact factor: 10.005

7.  Activation of the epidermal growth factor receptor: a series of twists and turns.

Authors:  David Poger; Alan E Mark
Journal:  Biochemistry       Date:  2014-04-17       Impact factor: 3.162

8.  The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules.

Authors:  C W Ward; T P Garrett
Journal:  BMC Bioinformatics       Date:  2001-07-27       Impact factor: 3.169

9.  Molecular basis for multimerization in the activation of the epidermal growth factor receptor.

Authors:  Yongjian Huang; Shashank Bharill; Deepti Karandur; Sean M Peterson; Morgan Marita; Xiaojun Shi; Megan J Kaliszewski; Adam W Smith; Ehud Y Isacoff; John Kuriyan
Journal:  Elife       Date:  2016-03-28       Impact factor: 8.140

10.  Enhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer.

Authors:  Christopher C Valley; Donna J Arndt-Jovin; Narain Karedla; Mara P Steinkamp; Alexey I Chizhik; William S Hlavacek; Bridget S Wilson; Keith A Lidke; Diane S Lidke
Journal:  Mol Biol Cell       Date:  2015-09-02       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.